Back
Harvard Bioscience Quote, Financials, Valuation and Earnings
My #1 Coin is...
All the details are on the next page.
Sell
37
HBIO
Harvard Bioscience
Last Price:
3.83
Seasonality Move:
-2.66%
7 Day Trial
ALL ACCESS PASS
$
7
Election Shock on August 19th?
Click here now to see the evidence I've gathered.Harvard Bioscience Price Quote
$3.83
+0.01 (+0.26%)
(Updated: May 2, 2024 at 6:55 PM ET)
Harvard Bioscience Key Stats
Sell
37
Harvard Bioscience (HBIO)
is a Sell
Day range:
$3.77 - $4.00
52-week range:
$3.44 - $6.28
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.45
P/B ratio:
2.27%
Volume:
141.8K
Avg. volume:
98.1K
1-year change:
-35.8%
Market cap:
$165.8M
Revenue:
$112.3M
EPS:
$-0.08
How Much Does Harvard Bioscience Make?
-
How Much Are Harvard Bioscience's Sales Annually?
HBIO Revenues are $112.3M -
How Much Profit Does Harvard Bioscience's Make A Year?
HBIO net income is -$3.4M
Is Harvard Bioscience Growing As A Company?
-
What Is Harvard Bioscience's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.01% -
What Is Harvard Bioscience's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Harvard Bioscience Stock Price Performance
-
Did Harvard Bioscience Stock Go Up Last Month?
Harvard Bioscience share price went down by -10.33% last month -
Did HBIO's Share Price Rise Over The Last Year?
HBIO share price fell by -35.8% over the past 1 year
What Is Harvard Bioscience 52-Week High & Low?
-
What Is Harvard Bioscience’s 52-Week High Share Price?
Harvard Bioscience has traded as high as $6.28 over the past 52 weeks -
What Is Harvard Bioscience’s 52-Week Low Share Price?
Harvard Bioscience has traded as low as $3.44 over the past 52 weeks
Harvard Bioscience Price To Free Cash Flow
-
Is Harvard Bioscience Stock Overvalued?
Harvard Bioscience is trading at a price to free cash flow ratio of 13.89 -
Is Harvard Bioscience Stock Undervalued?
Harvard Bioscience EV to Free Cash Flow ratio is 16.90 -
What Is Harvard Bioscience’s Price Earnings Growth Ratio?
HBIO PEG ratio is 0.00 -
Is Harvard Bioscience Trading At A Premium To Earnings?
Harvard Bioscience EV to EBIT ratio is 191.37
Is It Risky To Buy Harvard Bioscience?
-
How Much Debt Does Harvard Bioscience Have?
Total long term debt quarterly is $36.6M -
How Much Cash Does Harvard Bioscience Have?
Cash and short term investments quarterly total is $4.3M -
What Is Harvard Bioscience’s Book Value Per Share?
Book value per share is 1.68
Is Harvard Bioscience Cash Flow Positive?
-
What Is HBIO Cash Flow From Operations?
Cash flow from operations (TTM) is $14M -
What Is Harvard Bioscience’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$12.1M -
What Is Harvard Bioscience’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$1.8M
Harvard Bioscience Return On Invested Capital
-
Is Management Doing A Good Job?
HBIO return on invested capital is -2.96% -
What Is Harvard Bioscience Return On Assets?
ROA measures how assets are converting to revenues and is -2.4% -
What Is HBIO Return On Equity?
ROE is a measure of profitability and is -4.62%
Harvard Bioscience Earnings Date & Stock Price
-
What Is Harvard Bioscience's Stock Price Today?
A single share of HBIO can be purchased today for 3.82 -
What Is Harvard Bioscience’s Stock Symbol?
Harvard Bioscience trades on the nasdaq under the ticker symbol: HBIO -
When Is Harvard Bioscience’s Next Earnings Date?
The next quarterly earnings date for Harvard Bioscience is scheduled on May 7, 2024 -
When Is HBIO's next ex-dividend date?
Harvard Bioscience's next ex-dividend date is May 3, 2024 -
How To Buy Harvard Bioscience Stock?
You can buy Harvard Bioscience shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Harvard Bioscience Competitors
-
Who Are Harvard Bioscience's Competitors?
Below is a list of companies who compete with Harvard Bioscience or are related in some way:
Harvard Bioscience Dividend Yield
Data Unavailable
Harvard Bioscience Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -20% |
| Revenue: | -0.96% | -1.56% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 7.00 |
| Upside from Last Price: | 83.25% |